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Neonatal but not adult mice are vulnerable to reovirus invasion of the central nervous system after peripheral inoculation.
After hindlimb injection, type 3 reovirus travels via the sciatic nerve to replicate in spinal cord motor neurons before spread
to the brain and development of lethal encephalitis. Here we provide ultrastructural evidence for direct reovirus invasion of
unmyelinated neonatal motor nerve terminals within 2 h and replication in spinal cord motor neurons within 14 h after
hindlimb injection of 1-day-old mice. In adult mice, resistance to reovirus lethality after intracranial (IC) injection correlates
with the restriction of virus growth in cortical neurons. We found that neuroinvasion also is age dependent after intramuscular
injection. Virus lethality and CNS infection decreased sharply during the first postnatal week, while lethality after IC injection
continued for 2 additional weeks. Mice inoculated at 7 days of age with high virus doses suffered paralysis of the injectedINTRODUCTION
Neonatal mice are vulnerable to reovirus neuroinva-
sion from peripheral sites of infection. After hindlimb
injection, type 3 reovirus invades the sciatic nerve and
then travels by fast axonal transport to replicate in spinal
cord neurons before spread to the brain and the devel-
opment of encephalitis (Tyler et al., 1986). Although viral
antigen has been detected in ventral spinal cord neurons
ipsilateral to the injection site within 14 h after footpad
injection (Flamand et al., 1991), the details of when and
how virus invades neonatal sciatic nerve are not known.
Reovirus neurovirulence is age dependent, in that
newborn mice are highly susceptible to virus lethality
after intracranial (IC) injection but adult mice are resis-
tant to virus infection. One mechanism that has been
proposed for this difference is the age dependence of
virus proliferation in cortical neurons (Tardieu et al.,
1983). Although lethality by peripheral routes of injection
is also limited to neonatal animals, it is not known
whether restriction occurs only when virus reaches the
brain or if one or more steps in neuroinvasion after
hindlimb injection is age dependent.
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unit and that of the newborn (Slater, 1982; Salpeter, 1987;
Betz, 1987). In the adult, each spinal cord motor neuron
may innervate hundreds of muscle fibers via its
branched axon. Each of these muscle fibers is inner-
vated by only one branch at a single motor endplate, the
axon branch is myelinated, and the nerve–muscle junc-
tion is tightly “capped” by Schwann cells. By contrast, in
the newborn each muscle fiber receives axon terminals
from several motor neurons, the preterminal motor axons
are unmyelinated, and Schwann cells only loosely sur-
round the nerve–muscle junction. The excess of imma-
ture nerve terminals in the newborn allows for the post-
natal refinement of neural circuitry. Within 2 weeks after
birth, the number of nerve terminals has been reduced
by at least 50% as axon branches withdraw, leaving
singly innervated neuromuscular junctions, the remain-
ing axon terminal has been myelinated and the nerve-
muscle junction capped by Schwann cells (Colman and
Lichtman, 1993; Salpeter, 1987). Thus, during the first
days after birth, motor neurons may be especially vul-
nerable to reovirus invasion.
In this study, we wished to test the hypothesis that
after hindlimb injection type 3 reovirus directly invades
neonatal sciatic nerve terminals and to determine
whether one or more steps in reovirus neuroinvasion is
age dependent. We used reovirus type 3 clone 9 (C9),limb, but significant brain infection was not lethal. These
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good basis for comparison of subsequent age-related
and/or route-dependent differences.
RESULTS
Virus invasion of nerve terminals
To determine whether neonatal sciatic nerve terminals
are exposed to injected virus particles, we sacrificed
1-day-old mice at 90 min after hindlimb injection with C9
virus and examined thin sections of skeletal muscle by
electron microscopy. Near the injection site, virus parti-
cles appeared to be excluded from contact with larger
nerve branches by the perineural sheath of fibroblasts
(Fig. 1B) and many were engulfed by resident phago-
cytes (data not shown). As expected, the preterminal
axon (within 35 m of the synapse) was unmyelinated
(Fig. 1A). Here, we occasionally found virus particles
closely apposed to the axon membrane and the
Schwann cell that surrounded it (Fig. 1D). We also ob-
served reovirus particles among the axon profiles at
multiply innervated nerve–muscle junctions, but not at
the active zone where the basal lamina occupied the
interstitial space (Fig. 1C). Although muscle fiber profiles
were abundant in many sections, viral particles were
seen only occasionally in association with muscle mem-
brane.
At this early time point, we also found evidence of virus
uptake into the axonal cytoplasm. Virus particles were
seen in endosome-like vesicles near the active zone (Fig.
2A) and in preterminal axons (Figs. 2B and 2C). In addi-
tion to virus particles, these endosomes sometimes con-
tained small spherical profiles resembling synaptic ves-
icles (Fig. 2C). Single virus particles were seen also in
endosomes in muscle fibers and Schwann cells. Thus,
by 90 min after injection, reovirus particles had invaded
both sciatic nerve terminals and muscle fibers near the
injection site.
Because our micrographs suggested that the uptake
of reovirus particles might occur along the unmyelinated
preterminal motor axon as well as near the active zone in
newborn mice in vivo, we examined the uptake of C9
virus in primary cultures of mouse ventral spinal cord
neurons. In cultures fixed at 90 min after infection, we
found endosomes containing viral particles and spheri-
cal vesicles similar to those seen in 1-day-old mice (Fig.
3A). In addition, we observed a virus particle apparently
in the process of endocytosis in a vesicle with the elec-
tron-dense coat characteristic of a coated pit (Fig. 3B).
Because the vesicle membrane was still continuous with
the cell membrane, the axonal site of uptake was clear.
These results suggest that reovirus uptake may occur in
unmyelinated motor axons, such as those found in pri-
mary cell cultures and near the sciatic nerve terminals of
neonatal mice.
Kinetics of factory formation
If virus uptake into sciatic nerve terminals results in
productive infection, viral replication would be expected
to begin as infectious particles are transported to the
neural soma located in the ventral spinal cord. To deter-
mine whether virus replication occurs in the neonatal
spinal cord at a time consistent with direct infection of
sciatic nerve terminals, we prepared vibratome sections
from spinal cords collected at 15 and 19 h after C9
hindlimb injection. Infected neurons were identified by
immunohistochemical detection of viral antigen (Fig. 4A)
and subsequently examined by electron microscopy for
evidence of the distinctive cytoplasmic reovirus assem-
bly structures, viral “factories,” characteristic of reovirus
replication (Raine and Fields, 1973; Fig. 4B). As a stan-
dard for comparison of the morphology and kinetics of
factory formation, we prepared a time course of micro-
graphs of C9 infection of the mouse fibroblast cell line
used to grow and titer reovirus. In these cells, small
replication factories could be detected by 6 h after infec-
tion, and factories rapidly increased in number and size
over the next 6 h (Fig. 4C and Table 1).
Factory morphology in motor neurons in infected spi-
nal cords was similar to that seen in cell culture, but the
kinetics of factory formation were somewhat slower (Fig.
4C and Table 1). By 15 h after hindlimb injection, perinu-
clear replication factories in spinal cord motor neurons
contained up to 57 viral particles, and by 19 h after
injection they contained more than 200 particles. By
comparison, our examination of sections made from in-
fected muscle tissue collected at 12 h after IM inocula-
tion revealed factories similar to those found in spinal
cord neurons at 15 h. Thus, replication in hindlimb mus-
cle fibers was about 3 h ahead of that in spinal cord
neurons, suggesting that replication in spinal cord motor
neurons was well underway before progeny virus was
formed in muscle fibers. Given the distance that virus
must travel to reach the neural soma (about 14 mm), this
timing was consistent with a model in which virus inva-
sions of nerve terminal and muscle fiber are parallel
events, with the kinetics of viral replication reflecting the
different distances virus must travel before reaching the
cytoplasmic machinery necessary for viral replication.
Age dependence of neuroinvasion
To determine whether neuroinvasion of clone 9 virus
was dependent on the age of the mouse, we first mea-
sured 50% lethal doses (LD50) after inoculation by the IC
and IM routes in mice from 1 to 14 days of age (Fig. 5).
The LD50 after im injection increased rapidly until post-
natal day 7, when even the highest virus dose (109 pfu)
killed no mice. By contrast, the LD50 by the IC route
increased more gradually over 3 weeks. Thus, mice were
vulnerable to IC injection well after lethality had ceased
by the IM route. The route-specific difference in LD50
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FIG. 1. Virus association with sciatic nerve terminals at 90 min after IM injection. A. Multiple motor axons innervate a muscle fiber (lower left) at the
neuromuscular junction. The preterminal axon remains unmyelinated until synapse elimination has removed all but one motor terminal (Salpeter, 1987). In
this preterminal region, virus particles (arrows, upper left) can be found (see enlarged view in D). B. Virus particles accumulate at the membrane of perineural
cells (upper right) which surround a bundle of unmyelinated axons (lower left). C. Virus particles (arrowheads) are seen between two axon terminals. The
basal lamina (*) lies parallel to muscle and nerve membranes but is not seen between axon terminal membranes. D. Virus particles (arrowheads) were seen
between two axons, an axon and a Schwann cell (S), and in the interstitial space near collagen fibers. Note the cluster of synaptic vesicles (v) in an axon
near the center of the micrograph.
increased from less than 101 pfu in newborn mice to
greater than 105 pfu in 7-day-old mice, suggesting that
one or more early steps in reovirus invasion was age
dependent.
We next compared C9 viral growth in muscle and its
spread to spinal cord and brain in mice of increasing age
(Fig. 6). Tissue was collected on alternate days after
low-dose (103 pfu) IM injection (2–12 mice per time point,
total 111 mice). Virus grew well in muscle in mice up to
2 weeks of age, but titers were greatly reduced in
3-week-old mice. Virus rapidly spread to spinal cord and
brain in 1- and 3-day-old mice, but titers increased more
slowly in 7-day-old mice and were virtually absent in
2-week-old mice. These results suggested that both vi-
rus infection of skeletal muscle and invasion of the CNS
were age dependent. However, the gradual decrease in
virus growth at the injection site did not appear to ac-
count for the more rapid restriction of virus spread to
spinal cord and brain.
Although hindlimb injection was not lethal in 7-day-old
mice at any dose (Fig. 5), mice injected with high doses
of virus developed flaccid paralysis of the inoculated limb
by 7–9 days after injection. In these mice, spinal cord virus
titers reached 106 pfu within 7 days (Fig. 7). Brain titers
(107.7 pfu) were similar to those produced by lethal IC
injection of mice of the same age, yet no mice died,
suggesting a route-specific response to virus infection.
DISCUSSION
The pathogenesis of viral invasion of the CNS involves
many distinct steps, including replication at the primary
site of infection, entry and spread within the CNS, growth
in neural tissue, host immune response, and tissue injury
(Tyler and Fields, 1996). Each of these steps may be
FIG. 3. Endocytosis of reovirus into primary neurons in culture. A. A
single virus particle in an endosome containing several small vesicles
at 90 min after infection of ventral spinal cord cultures. Microtubules
(m); bar, 100 nm. B. Virus particle in the process of endocytosis.
FIG. 2. Reovirus uptake in the neonatal nerve at 90 min after hindlimb
injection. A. A single virus particle (arrowhead) is seen enclosed in a
large endosome in the synaptic region of a nerve–muscle junction.
Synaptic vesicles cluster at the active zone. B. Endosome in a preter-
minal axon containing a virus particle (arrowhead near center of mi-
crograph) along with a small spherical vesicle. A large mitochondrion
occupies the center of the axon. Note a second virus particle (upper-
most arrowhead) in the space between axons. C. An endosome in a
preterminal axon containing a virus particle (arrowhead) along with
several small spherical vesicles. The abundance of microtubules (m)
suggests that this micrograph represents a region farther from the
active zone than that in B.
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influenced by viral and/or host factors. Reovirus infection
of neonatal mice has provided a useful animal model for
studying the pathogenesis of virus-induced CNS dis-
ease. Using neurotropic type 3 clone 9 reovirus, we
provide evidence for direct virus invasion of immature
motor nerve terminals and demonstrate age dependence
at several steps in neuroinvasion after hindlimb injection
of newborn mice.
Direct entry into nerve terminals
After hindlimb injection, type 3 reovirus rapidly invades
the spinal cord and brain of newborn mice. Virus first
appears in the inferior spinal cord, where viral antigen
has been detected in motor neurons within 14 h after
injection (Flamand et al., 1991). However, immunohisto-
chemical detection of viral antigen cannot distinguish
FIG. 4. Kinetics of virus replication in spinal cord neurons. A. By 15 h after IM injection of 1-day-old mice, a small number of C9 virus-infected ventral
spinal cord neurons can be detected by immunohistochemistry (note the neuron with a lightly stained cytoplasm near the center of micrograph). B.
Ultrastructural examination of these stained cells (A) allows visualization of individual viral particles in replication factories in neural cytoplasm. Image
shown is from a thin section stained with uranyl acetate and lead citrate. C. Comparison of the number of virus particles in the largest viral factories
found by ultrastructural examination of ventral spinal cord neurons at 15 and 19 h after IM injection and in L-cell cultures at 1, 6, 8, 10, and 12 h after
infection. *Number of virus particles in the largest factory found in thin sections of infected muscle fibers 12 h after hindlimb injection.
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among endocytosed viral particles, early viral protein
synthesis, and newly assembled viral particles. Thus it
could not be determined whether virus had replicated in
the neural soma after direct entry at the nerve terminal or
had been transported to the neural cell body after repli-
cation in muscle fibers.
By ultrastructural examination of infected neonatal tis-
sue in this study, we were able to trace early events in C9
neuroinvasion following IM injection. Rather than accu-
mulation of injected virus particles at the muscle mem-
brane or preferential uptake in the postsynaptic muscle
cytoplasm, we observed single reovirus particles in en-
dosomes in muscle fibers as well as in the unmyelinated
preterminal motor axons characteristic of immature
nerve–muscle junctions. Thus, reovirus infection of mus-
cle and nerve appear to be parallel events, occurring
within 90 min after hindlimb inoculation.
In mature neurons, endocytosis occurs in the preter-
minal axonal membrane at the margins of the active
zone, where synaptic vesicle membrane is recycled after
transmitter release (Brodin et al., 2000; Heuser and
Reese, 1973). However, in developing neurons synaptic
vesicle recycling also occurs along axons and may play
a trophic role during the maturation of innervation (Mat-
teoli et al., 1992). Although nerve–muscle junctions are
formed before birth, the motor nerve terminals mature
during postnatal remodeling as polyneuronal innervation
is eliminated and the preterminal axonal membrane is
myelinated. In our study, this immature region of the
motor terminal appears to be vulnerable to reovirus in-
vasion. Whether axon terminals withdrawing from multi-
ply innervated endplates, terminals moving from multiply
innervated endplates to form synapses on adjacent sec-
ondary muscle fibers (Duxon et al., 1986), or the single
terminal which remains to innervate the mature neuro-
muscular junction is the primary target for reovirus inva-
sion is a subject for further study.
Using sciatic nerve section and colchicine treatment,
Tyler et al. (1986) demonstrated that reovirus travels to
the spinal cord via the microtubule-associated system of
fast axonal transport. Because reovirus particles can
associate with microtubules when replicating in infected
cells (Raine and Fields, 1973; Parker et al., 2002) and with
isolated microtubule preparations in vitro (Babiss et al.,
1979), it has been suggested that virus particles may be
transported directly on microtubules. However, at least
TABLE 1
Cells and Factories Examined in Thin Sections
Time point No. cells No. factories
L cells 6 h 5 0
8 h 5 8
10 h 8 14
12 h 8 25
Neurons 15 h 13 56
19 h 9 85
Muscle 12 h 4 20
FIG. 5. C9 LD50 in mice of increasing ages. Each point represents the 50% lethal dose (LD50) for groups of mice injected at the indicated age with
various doses of C9 virus by the intracranial (IC) or intramuscular (IM) route. *No lethality, even at highest dose.
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early in infection of neonatal motor nerve and primary
neural cell cultures, C9 virus appears to travel in endo-
somes (Figs. 2B and 2C; Fig. 3A).
Viral entry into the endosome–lysosome degradation
pathway activates viral replication as lysosomal pro-
teases uncoat the virus particle during transport to the
perinuclear cytoplasm where progeny viral particles are
formed (Nibert et al., 1996). Retrograde fast axonal trans-
port moves at 2–3 mm/h in vivo, somewhat more slowly
than in cell culture (Nathanson and Tyler, 1997). Thus, the
viral factories we observe in motor neurons in the ventral
spinal cord at 15 h after IM injection may reflect 4–7 h of
axonal transport. Consistent with ultrastructural evi-
dence for direct virus penetration of immature motor
nerve terminals, factory formation within 15 h postinocu-
lation suggests that prior replication in muscle fibers is
not required for reovirus invasion of neonatal peripheral
nerve. However, as with rabies virus, replication at the
injection site may amplify the viral inoculum and contrib-
ute to continuing spread to the CNS (Charlton et al., 1997;
Flamand et al., 1991).
Direct virus invasion of peripheral nerve and spread by
fast axonal transport appear to be common features of
neurotropic viruses (reviewed in Tyler and Gonzalez-
Scarano, 1997). Rabies virus, like reovirus, enters neural
pathways after hindlimb injection. However, invasion is
species and strain specific but not age dependent
(Watson et al., 1981; Coulon et al., 1989; Shankar et al.,
1991). The proposed site of entry is the nerve–muscle
junction, where rabies virus particles accumulate by
binding to acetylcholine receptors in the postsynaptic
muscle membrane (Lentz et al., 1982; Lewis et al., 2000).
Such binding may position viral particles for subsequent
entry into the presynaptic nerve terminal by binding to
neural acetylcholine or P75 receptors (Tuffereau et al.,
1998). In our study, reovirus particles did not appear to
accumulate at the postsynaptic muscle membrane but
were taken up into the preterminal axon. Reovirus is
known to bind to sialic acid residues (Tyler, 1998) and to
junction adhesion molecule (Barton et al., 2001); how-
ever, the nature of the reovirus receptor on neonatal
nerve terminals remains to be defined.
Age dependence of pathogenesis
It has been shown previously that T3D lethality after IC
injection is restricted within 10 days after birth and cor-
relates with decreased capacity of cranial neurons to
support virus replication (Tardieu et al., 1983). We found
a somewhat longer susceptibility of neonatal mice to IC
injection with C9 virus. This may reflect differences in
FIG. 7. Virus growth in 7-day-old mice. The curves represent virus
titers in muscle spinal cord or brain after intramuscular injection of
7-day-old mice with C9 (109 pfu). Points represent mean titers  SE.
*C9 brain titer 7 days after IC injection (107 pfu/mouse) of 7-day-old
mice.
FIG. 6. Virus spread in mice of increasing ages after IM injection.
Curves represent the titer of C9 reovirus in muscle (A), spinal cord (B),
or brain (C) in groups of mice injected with 103 pfu of C9 at the indicated
ages and sacrificed at days 1, 3, 5, or 7 postinjection. Points represent
mean titers  SE.
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virus stocks rather than an intratypic difference between
reoviruses because we observed T3D LD50 values simi-
lar to those of C9 virus in mice of up to 2 weeks of age
(data not shown). However, in 1-day-old mice, the LD50 of
the virus used in the previous study was 100-fold greater
than that of our laboratory stock, a difference that may
account for the more rapid decline in lethality after IC
injection.
Age-dependent restriction of C9 lethality after IM in-
jection appears at both early and late steps in invasion,
but with different time courses. The restriction of virus
grow at the injection site develops over the first 3 weeks
after birth. Age-related restriction of virus entry and/or
spread to the CNS develops more rapidly, and reductions
in spinal cord and brain infection correlate with reduc-
tions in virus lethality. Thus, while both muscle and brain
remain vulnerable to virus infection for up to 3 weeks,
lethal neuroinvasion is limited to the first postnatal week.
Although brain titers comparable to those produced by
lethal IC injection of 7-day-old mice were produced by
high-dose IM injection, the mice did not appear to suffer
symptoms of encephalitis and no mice died, suggesting
additional route-specific mechanisms. Future studies
will determine whether differences in antigen distribution
and/or induction of apoptosis occur in the brain as mice
mature. Immune responses may also be altered in the
7-day-old mouse, and anti-reovirus antibody response
and cytokine induction will be measured in IC- and IM-
inoculated mice. Recent studies demonstrate that C9
viral replication induces IL-1 in the brains of neonatal
but not adult mice, suggesting that the neonatal immune
response may contribute to reovirus lethality (Derrien
and Fields, 1999). However, induction is not dependent
on the route of inoculation, and the response of 7-day-old
mice has not yet been determined. Lawson and Perry
(1995) report that the neonatal inflammatory response
undergoes an abrupt but transitory increase in 1-week-
old mice, exceeding that of both the newborn and the
adult. Thus, in 7-day-old mice, intracranial injection of
virus may elicit a protective response not produced by
the nontraumatic introduction of virus by neural trans-
port.
Induction of limb paralysis by high-dose IM injection of
7-day-old mice suggests that the mechanism that limits
the lethality of brain infection in mice of this age does not
protect spinal cord neurons from injury. Paralysis has not
been a feature of recent reports of T3D and C9 infection.
Early reports of reovirus type 3 hepatoencephalomyelitis
virus described paralysis as an early symptom of lethal
infection in neonates (Papadimitriou, 1966). C9-induced
paralysis without lethality in maturing mice resembles
poliovirus infection, in which adolescents are suscepti-
ble to nonlethal limb paralysis (Jubelt et al., 1980).
Taken together, our results suggest that reovirus inva-
sion of the developing CNS after hindlimb injection is
limited by several progressive age-dependent mecha-
nisms, including a decrease in the number of motor
nerve terminals at each neuromuscular junction and an
increase in myelination of preterminal motor axons dur-
ing the maturation of innervation, a gradual restriction of
virus replication in muscle and brain, a more rapid re-
striction of virus spread to the CNS, and a dramatic
reduction in the lethality of brain infection initiated by
intramuscular injection by 1 week after birth.
MATERIALS AND METHODS
Cells
Spinner-adapted mouse fibroblast L929 cells (L-cells)
(ATCC) were grown either in suspension or monolayer
cultures in Joklik’s modified Eagle’s minimal essential
medium (Irvine Scientific) supplemented with 5% fetal
bovine serum (HyClone Laboratories) and 2 mM L-glu-
tamine, 1 U of penicillin, and 1 g of streptomycin per
milliliter (Irvine Scientific). Neural cell cultures were pre-
pared from embryonic day-13 mouse ventral spinal cords
by the method of Guthrie et al. (1987).
Viruses
Type 3 reovirus strains Dearing and clone 9 were
previously described laboratory stocks (Hrdy et al., 1979).
Viruses were doubly plaque purified and passaged in
L-cells to generate working stocks as described previ-
ously (Tyler et al., 1985). Purified T3D and C9 viruses
were prepared from L-cell lysates by cesium chloride
gradient centrifugation (Furlong et al., 1988).
Animals and inoculations
One-day-old Swiss Webster (Taconic) or NIH Swiss
(National Cancer Institute) mice received inoculations
intracerebrally in the right hemisphere or intramuscularly
in the left hind limb with a Hamilton syringe and 30-
gauge needle. Tissue samples for viral titration were
collected in gelatin–saline (0.3% gelatin in phosphate-
buffered saline) and stored at80°C. To determine virus
lethality, at least three groups of mice (five to six mice per
group) were inoculated with serial dilutions of each virus
and monitored daily for signs of morbidity. Experiments
were terminated at 21 days postinfection, and 50% lethal
doses were calculated by the method of Reed and
Muench (1938). Mice were maintained in an American
Association for the Accreditation of Laboratory Animal
Care-approved facility.
Determination of viral titer
Tissue samples for titration were frozen and thawed
three times and then sonicated for 30 s using a microtip
probe to homogenize tissue. Serial 10-fold dilutions were
inoculated onto L-cell monolayers (106 cells per well) in
six-well plates (Corning). Duplicate wells were inocu-
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lated with each of three dilutions, and the titer was
determined by standard plaque assay (Tyler et al., 1985).
Detection of viral antigens
Reovirus antigens were detected in paraformalde-
hyde-fixed vibratome sections by the immunoperoxidase
method using a rabbit polyclonal anti-T3D antiserum
(Tyler et al., 1989) and a Vectastain Elite ABC reagent kit
(Vector Laboratories).
Electron microscopy
Virus antigen-positive areas of spinal cord or muscle
vibratome sections were postfixed in uranyl acetate, em-
bedded in epon–araldite, sectioned, and stained with
lead citrate and uranyl acetate. Grids were examined
using Hitachi or Joel transmission electron microscopes.
L-cell or neural cell cultures were infected with C9 at a
m.o.i. of 100 pfu per cell and incubated at 37°C for 1–14
h. Cells were fixed in 4% paraformaldehyde/0.05% glu-
teraldehyde and processed for electron microscopy.
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